PharmGKB summary: atazanavir pathway, pharmacokinetics/pharmacodynamics.
Maria Alvarellos, Chantal Guillemette, Russ B Altman, Teri E Klein
Author Information
- Maria Alvarellos: Departments of Biomedical Data Science.
- Chantal Guillemette: Faculty of Pharmacy, University Hospital Center of Quebec (CHU), Laval University, Quebec City, Quebec, Canada.
- Russ B Altman: Genetics.
- Teri E Klein: Departments of Biomedical Data Science.
No abstract text available.
- Pharmacogenomics. 2007 Mar;8(3):227-35
[PMID: 17324111]
- J Acquir Immune Defic Syndr. 2013 May 1;63(1):59-66
[PMID: 23392467]
- Clin Infect Dis. 2010 Jul 1;51(1):101-6
[PMID: 20504240]
- Clin Pharmacol Ther. 2016 Apr;99(4):363-9
[PMID: 26417955]
- Clin Infect Dis. 2012 Nov;55(9):1270-2
[PMID: 22820540]
- PLoS One. 2015 Sep 11;10 (9):e0137660
[PMID: 26360703]
- Mol Pharm. 2013 Aug 5;10 (8):3067-75
[PMID: 23750830]
- HIV Clin Trials. 2015 May-Jun;16(3):89-99
[PMID: 25979186]
- Pharmacogenet Genomics. 2017 May;27(5):201-209
[PMID: 28277330]
- Hepatology. 2006 Nov;44(5):1324-32
[PMID: 17058217]
- J Antimicrob Chemother. 2015 Nov;70(11):3096-9
[PMID: 26174719]
- J Infect Dis. 2005 Oct 15;192(8):1381-6
[PMID: 16170755]
- Adv Pharmacol. 2013;67:317-58
[PMID: 23886005]
- J Clin Pharmacol. 2017 Feb;57(2):235-246
[PMID: 27432796]
- Ann Hum Genet. 2011 Mar;75(2):236-46
[PMID: 21309756]
- Pharmacogenet Genomics. 2014 Mar;24(3):177-83
[PMID: 24492252]
- J Mass Spectrom. 2013 Jun;48(6):640-50
[PMID: 23722954]
- Pharmacogenet Genomics. 2011 Mar;21(3):152-61
[PMID: 20216335]
- J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):431-2
[PMID: 19858926]
- Clin Infect Dis. 2014 Feb;58(4):555-63
[PMID: 24253247]
- J Antimicrob Chemother. 2010 Jan;65(1):129-37
[PMID: 19897506]
- J Antimicrob Chemother. 2009 Nov;64(5):1071-9
[PMID: 19710077]
- AIDS. 2015 Sep 10;29(14 ):1775-83
[PMID: 26372383]
- Pharm Res. 2014 Sep;31(9):2404-19
[PMID: 24595498]
- Top Antivir Med. 2017 Dec/Jan;24(4):132-133
[PMID: 28208121]
- Antivir Ther. 2015;20(1):57-64
[PMID: 24992294]
- J Antimicrob Chemother. 2014 Dec;69(12):3320-8
[PMID: 25151207]
- Xenobiotica. 2010 Mar;40(3):163-76
[PMID: 20102298]
- Infect Dis Clin North Am. 2014 Sep;28(3):371-402
[PMID: 25151562]
- Clin Infect Dis. 2012 Nov;55(9):1262-9
[PMID: 22820542]
- Lancet. 2008 Aug 23;372(9639):646-55
[PMID: 18722869]
- J Infect Dis. 2006 Sep 15;194 Suppl 1:S51-8
[PMID: 16921473]
- Pharmacogenet Genomics. 2018 Jan;28(1):1-6
[PMID: 29117017]
- Drugs. 2012 Jun 18;72(9):1161-73
[PMID: 22646049]
- Pharmacotherapy. 2004 Dec;24(12):1732-47
[PMID: 15585441]
- Br J Clin Pharmacol. 2011 Dec;72(6):940-7
[PMID: 21649692]
- J Antimicrob Chemother. 2012 Sep;67(9):2236-42
[PMID: 22661571]
- J Antimicrob Chemother. 2014 Nov;69(11):3061-6
[PMID: 24997317]
- Drug Metab Dispos. 2009 Sep;37(9):1826-40
[PMID: 19546238]
- J Infect Dis. 2013 Feb 1;207(3):420-5
[PMID: 23148286]
- Pediatr Res. 2016 Mar;79(3):378-86
[PMID: 26595536]
- Antimicrob Agents Chemother. 2011 Sep;55(9):4290-4
[PMID: 21670182]
- HIV AIDS (Auckl). 2015 Oct 27;7:251-64
[PMID: 26604826]
- Clin Infect Dis. 2006 Jan 15;42(2):291-5
[PMID: 16355344]
- Infect Dis Clin North Am. 2014 Sep;28(3):421-38
[PMID: 25151564]
- HIV Med. 2014 May;15(5):301-10
[PMID: 24314017]
- Open Forum Infect Dis. 2015 Jul 01;2(3):ofv085
[PMID: 26180834]
- J Microbiol Immunol Infect. 2017 Dec;50(6):789-797
[PMID: 26857335]
- Pharm Res. 2013 Apr;30(4):1050-64
[PMID: 23224979]
- J Antimicrob Chemother. 2016 Jun;71(6):1609-18
[PMID: 26892777]
- Clin Pharmacokinet. 2005;44(10):1035-50
[PMID: 16176117]
- Clin Infect Dis. 2008 Nov 1;47(9):1222-5
[PMID: 18831695]
- J Antimicrob Chemother. 2010 Aug;65(8):1672-80
[PMID: 20551216]
- AIDS. 2007 May 31;21(9):1215-8
[PMID: 17502736]
- Pharmacogenomics. 2014 Jul;15(10 ):1281-6
[PMID: 25155930]
- PLoS One. 2013 Oct 10;8(10):e77268
[PMID: 24130871]
- J Med Chem. 2012 May 24;55(10 ):4740-63
[PMID: 22541068]
- PLoS One. 2013 Jul 16;8(7):e69845
[PMID: 23875004]
- Drug Metab Dispos. 2011 Mar;39(3):394-401
[PMID: 21148252]
- Drug Metab Dispos. 2011 Mar;39(3):522-7
[PMID: 21148251]
- J Infect Dis. 2011 Jan 15;203(2):246-57
[PMID: 21288825]
- Antimicrob Agents Chemother. 2008 Feb;52(2):631-7
[PMID: 18025112]
- Eur J Clin Pharmacol. 2007 Oct;63(10):935-40
[PMID: 17665183]
- J Acquir Immune Defic Syndr. 2013 Jan 1;62(1):60-6
[PMID: 23011396]
- Antimicrob Agents Chemother. 2010 Dec;54(12 ):5242-50
[PMID: 20921307]
- J Antimicrob Chemother. 2014 Dec;69(12):3300-10
[PMID: 25159623]
- J Antimicrob Chemother. 2014 May;69(5):1385-9
[PMID: 24379301]
- J Int AIDS Soc. 2014 Nov 02;17(4 Suppl 3):19560
[PMID: 25394067]
- Pharmacogenet Genomics. 2014 Apr;24(4):195-203
[PMID: 24557078]
- Pharmacogenet Genomics. 2010 Feb;20(2):112-20
[PMID: 20051929]
- J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):412-9
[PMID: 21283017]
- AIDS. 2007 Jan 2;21(1):41-6
[PMID: 17148966]
- AIDS Res Hum Retroviruses. 2012 Oct;28(10):1227-34
[PMID: 22394315]
- J Acquir Immune Defic Syndr. 2015 May 1;69(1):e36-7
[PMID: 25622064]
- R24 GM061374/NIGMS NIH HHS
- MOP#42392/Canadian Institute of Health Research
ATP Binding Cassette Transporter, Subfamily B
Atazanavir Sulfate
Drug Synergism
Glucuronosyltransferase
HIV Infections
HIV Protease Inhibitors
Humans
Liver-Specific Organic Anion Transporter 1
Pharmacogenetics
Pregnane X Receptor
Ritonavir
ABCB1 protein, human
ATP Binding Cassette Transporter, Subfamily B
HIV Protease Inhibitors
Liver-Specific Organic Anion Transporter 1
NR1I2 protein, human
Pregnane X Receptor
SLCO1B1 protein, human
Atazanavir Sulfate
UGT1A1 enzyme
Glucuronosyltransferase
Ritonavir